HCWB hcwbiologics.com: Multiplikator Forward P/S
Fierce competition with biotech giants for patient access creates risks for HCW Biologics Inc. (HCWB). The forward P/S indicator reflects current market dynamics, where the metric is fixed at 0.30. Price stability is supported by a strong team of immunologists and generous stock options. Growth prospects are based on the implementation of new therapeutic platforms to attract significant investment capital.
Rincian metrik komprehensif lan analitis hcwbiologics.com (HCWB)
- rega saiki lan proyeksi nilai saham:
- data kapitalisasi saham perusahaan:
- statistik nilai buku emiten:
- informasi babagan utang lan solvabilitas:
Rasio Total Utang marang Ekuitas HCW Biologics Inc.|HCWB - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang modal HCW Biologics|HCWB - Utang perusahaan|Utang-utang marang kapitalisasi buku HCW Biologics|HCWB - Gunggunge utang jangka dawa|Utang jangka cendhak perusahaan HCW Biologics|Likuiditas cepet hcwbiologics.com
- rincian asil keuangan lan kelipatan valuasi:
HCWB - Bathi resik perusahaan|Bathi sing dikarepake HCW Biologics Inc.|HCWB - Kapitalisasi marang bathi|Pangali Forward P/E HCW Biologics|HCWB - Rasio rega marang wutah bathi resik|Pangali EV/EBITDA HCW Biologics|HCWB - Pendapatan operasional sadurunge ngurangi amortisasi|Bathi resik saben saham (EPS TTM) HCW Biologics|HCWB - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan hcwbiologics.com|HCWB - Prakiraan wutah bathi resik saben saham ing taun iki|Prakiraan wutah bathi saben saham kanggo taun ngarep HCW Biologics Inc.
- data dodolan lan asil:
Ringkesan analitik perusahaan:HCW Biologics Inc HCWB
HCW Biologics Inc. (HCWB) resilience to market volatility is driven by the efficiency of cleanroom modernization and current capacity utilization for immunotherapy production. The company's modeled P/S ratio compares current market capitalization with expected sales volume, allowing investors to use this chart's price action to distinguish temporary crowd panic from a fundamental weakening of the asset, thereby ensuring an objective valuation of the business.
Analisis perusahaan pesaing
Multiplikator Forward P/S ARGX (argenx)|BioNTech Inc. (BNTX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Abivax Corp - Multiplikator Forward P/S|Rega forward marang dodolan ADMA (ADMA Corp)|PTGX: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan immunovant.com|Multiplikator forward rega marang pendapatan KNSA|Multiplikator forward rega marang pendapatan Grifols SA (GRFS)|Multiplikator forward rega marang pendapatan ADPT (Adaptive Biotechnologies Corp)|CLDX (Celldex Corp) - Rega forward marang dodolan|Multiplikator Forward P/S AUPH (Aurinia Pharmaceuticals)|biocryst.com - Rasio rega marang prakiraan pendapatan|Vera Therapeutics - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake Dianthus Therapeutics Inc DNTH|Pharvaris Corp (PHVS) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep AbCellera Corp (ABCL)|Rasio rega marang prakiraan pendapatan Tourmaline Bio, Inc.|Rasio rega marang prakiraan pendapatan PGEN|Rasio rega marang prakiraan pendapatan Pharming Group (PHAR)|NKTR - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Multiplikator Forward P/S UPB (Upstream Bio Corp)|Prakiraan rega marang pendapatan Zenas Corp|Immunome, Inc. - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake gossamerbio.com GOSS|KALV: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Septerna, Inc.|Rasio rega marang prakiraan pendapatan Pieris Pharmaceuticals Inc|Savara Pharma (SVRA) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator forward rega marang pendapatan RIGL (Rigel Pharmaceuticals)|ANAB (anaptysbio.com) - Rega forward marang dodolan|Multiplikator Forward P/S ATXS (Astria Therapeutics, Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake enGene Holdings Inc (ENGN)|RAPT - Rasio rega marang prakiraan pendapatan|JBIO (Aerovate Therapeutics Inc) - Kapitalisasi marang prakiraan pendapatan|ACRS: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan kyvernatx.com|Multiplikator forward rega marang pendapatan TLSA|Cabaletta Bio Inc. (CABA) - Rasio kapitalisasi marang dodolan sing dikarepake|Multiplikator Forward P/S VTYX|THTX (Theratechnologies, Inc) - Rega forward marang dodolan|Multiplikator Forward P/S AVTX (Avalo Therapeutics, Inc)|ELDN - Multiplikator forward rega marang pendapatan|AGEN: Multiplikator forward rega marang pendapatan|Climb Bio Inc. (CLYM) - Multiplikator forward rega marang pendapatan|ZURA: Multiplikator Forward P/S|ATYR (aTyr Pharmaceuticals) - Rasio rega marang prakiraan pendapatan|Rasio rega marang prakiraan pendapatan Adagene Inc|Ikena Oncology, Inc. - Rega mangsa ngarep marang pendapatan|Multiplikator Forward P/S STTK|EQ (equilliumbio.com) - Rega forward marang dodolan|Multiplikator Forward P/S CNTB (Connect Biopharma Holdings Limited)|Multiplikator Forward P/S Immunic Therapeutics IMUX|ATRA - Rasio rega marang prakiraan pendapatan|Rega forward marang dodolan IFRX (InflaRx N.V.)|X4 Pharmaceuticals, Inc. (XFOR) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan Adicet Bio, Inc.|CELU (Celularity Inc) - Multiplikator Forward P/S|Multiplikator Forward P/S INmune Bio Corporation|Multiplikator forward rega marang pendapatan BRNS (Barinthus Biotherapeutics)|KZR (kezarlifesciences.com) - Rega forward marang dodolan|Multiplikator Forward P/S SABS (SAB Biotherapeutics, Inc.)|Rasio kapitalisasi marang dodolan sing dikarepake Akari Therapeutics PLC (AKTX)|ENLV - Rasio rega marang prakiraan pendapatan|Q32 Bio Inc. (QTTB) - Multiplikator forward rega marang pendapatan|GeoVax Labs, Inc. (GOVX) - Rasio rega marang prakiraan pendapatan|Multiplikator forward rega marang pendapatan edesabiotech.com|Multiplikator forward rega marang pendapatan IBIO|Multiplikator Forward P/S Carisma Tx|Rasio rega marang prakiraan pendapatan XTL Biopharmaceuticals, Ltd. (XTLB)|boltbio.com - Kapitalisasi marang prakiraan pendapatan|Multiplikator Forward P/S APVO (Aptevo Therapeutics Inc.)|AIM ImmunoTech, Inc. (AIM) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|Aditxt Corp - Multiplikator Forward P/S|Rega forward marang dodolan GRI (GRI Bio Inc)|XRTX: Multiplikator Forward P/S|Multiplikator forward rega marang pendapatan Vyome Therapeutics|Multiplikator forward rega marang pendapatan REVB|Multiplikator forward rega marang pendapatan indaptusrx.com (INDP)|Multiplikator forward rega marang pendapatan SCNI (Scinai Immunotherapeutics Ltd.)|CALI (calcimedica.com) - Rega forward marang dodolan|Multiplikator Forward P/S AFMD (Affimed N.V.)|Allakos Inc - Rasio rega marang prakiraan pendapatan|HOOKIPA - Multiplikator Forward P/S|Rasio kapitalisasi marang dodolan sing dikarepake IGM Biosciences, Inc. IGMS|iTeos Therapeutics, Inc. (ITOS) - Rasio rega marang prakiraan pendapatan|Rasio kapitalisasi pasar marang pendapatan mangsa ngarep Ocean Biomedical Inc (OCEA)|Rasio rega marang prakiraan pendapatan TC BioPharm (Holdings) PLC|Rasio rega marang prakiraan pendapatan THRD
